Composition with function of conditioning exocrine gland and preparation method thereof
Through a composition containing a compound natural extract and modified squalane, the problem that existing skin care products cannot regulate exocrine gland function is solved, the skin inflammation reduction, sebum secretion regulation and moisturizing effects are achieved, and the skin is promoted. Self-healing and barrier function recovery.
Patent Information
- Application Number
- CN202411191437.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-28
- Publication Date
- 2024-11-26
AI Technical Summary
Existing skin care products cannot deeply regulate the exocrine dysfunction of the skin, making skin problems difficult to solve for a long time and may reduce the skin's ability to repair itself.
Using a composition, made of composite natural extracts, octyl polymethylsiloxane, polydimethylsiloxane, modified squalane, lauryl PEG-9 polydimethylsiloxane Methsiloxane, cetyl PEG/PPG-10/1 polydimethylsiloxane, hydrogenated polyisobutylene, disteardimethylammonium hectorite, preservatives, moisturizers and antioxidants, etc. Through the emulsion-gel form, sebum secretion and water-oil balance are regulated, and skin self-healing is promoted.
Significantly alleviates skin inflammation, regulates sebum secretion, enhances skin moisturizing ability, maintains skin barrier function, promotes skin cell repair and regeneration, and improves the overall health of the skin.
Smart Images

Figure CN119015198A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of cosmetics, and in particular relates to a composition having the function of regulating exocrine glands and a preparation method thereof. Background Art
[0002] The skin is the largest organ in the human body and serves as the first line of defense to protect the body from external environmental damage. In the complex structure of the skin, exocrine glands (including sweat glands and sebaceous glands) play a key role. These glands help regulate body temperature, maintain the water and oil balance on the skin surface, and provide natural barrier protection by secreting sweat and sebum. However, abnormalities in the function of exocrine glands, such as excessive or insufficient sebum secretion, often lead to the occurrence of skin problems, especially during the skin repair process.
[0003] In modern society, due to environmental pollution, stressful life, irregular diet and cosmetic abuse, more and more people are facing the problem of exocrine gland dysfunction. Excessive sebum secretion may cause clogged pores, acne and skin inflammation, while insufficient secretion leads to dry, rough and sensitive skin. These problems not only affect the health of the skin, but also have a negative impact on the individual's appearance and psychology.
[0004] Most of the skin care products on the market, especially face creams, focus on replenishing moisture to the skin, providing antioxidants or accelerating cell renewal. Although these products can improve skin conditions in the short term, they often only solve the problem superficially and cannot deeply regulate the root cause of the skin - exocrine gland dysfunction. More importantly, after long-term use, these products may increase the skin's dependence on the external environment, reduce the skin's self-repair ability, and further aggravate skin problems. Therefore, how to fundamentally restore the skin's natural repair ability by regulating the function of the exocrine glands has become a major challenge in the current skin care field. To this end, it is extremely necessary to develop a cream composition that has the function of regulating the exocrine glands, thereby restoring the normal barrier function of the skin and promoting the self-repair of damaged skin. Summary of the invention
[0005] In view of the defects of the prior art, the object of the present invention is to provide a composition having the function of regulating exocrine glands and a preparation method thereof.
[0006] The technical effect of the present invention is achieved through the following technical scheme: a composition with the function of regulating exocrine glands, the composition is composed of the following raw materials in parts by weight: 30 to 40 parts of composite natural extracts, 20 to 30 parts of octyl polymethylsiloxane, 15 to 25 parts of polydimethylsiloxane, 10 to 20 parts of modified squalane, 5 to 10 parts of lauryl PEG-9 polydimethylsiloxyethyl polydimethylsiloxane, 3 to 7 parts of cetyl PEG / PPG-10 / 1 polydimethylsiloxane, 5 to 10 parts of hydrogenated polyisobutene, 7 to 14 parts of disteardimonium hectorite, 0.5 to 1 part of preservatives, 5 to 10 parts of moisturizers and 0.5 to 1 part of antioxidants, and 100 to 120 parts of deionized water.
[0007] Preferably, the composite natural extract is composed of the following raw materials in parts by weight: 5 to 10 parts of purslane extract, 3 to 5 parts of Rhodiola rosea root extract, 2 to 5 parts of peony extract, 2 to 4 parts of chamomile oil, 3 to 6 parts of Platycladus orientalis leaf extract, 4 to 8 parts of loquat leaf extract, 2 to 5 parts of saffron flower extract, 3 to 5 parts of Cynomorium songaricum extract and 3 to 6 parts of Selaginella extract.
[0008] Preferably, the purslane extract is prepared by a hot reflux extraction process using ethanol as solvent.
[0009] Preferably, the Rhodiola rosea root extract is prepared by a hot reflux extraction process using ethanol as a solvent.
[0010] Preferably, the peony extract is prepared by a hot reflux extraction process using ethanol as a solvent.
[0011] Preferably, the chamomile oil is prepared by a steam distillation extraction process using water as a solvent.
[0012] Preferably, the Platycladus orientalis leaf extract is prepared by a hot reflux extraction process using ethanol as solvent.
[0013] Preferably, the loquat leaf extract is prepared by a hot reflux extraction process using ethanol as solvent.
[0014] Preferably, the saffron flower extract is prepared by using an ethanol-water mixed solvent and an ethanol-water reflux extraction process.
[0015] Preferably, the Cynomorium songaricum extract is prepared by ultrasonic-assisted extraction using an ethanol-water mixed solvent.
[0016] Preferably, the Selaginella extract is prepared by ultrasonic-assisted extraction using an ethanol-water mixed solvent.
[0017] Preferably, the specific preparation steps of the modified squalane are as follows: A1: Add squalane and linoleic acid into a reactor, then add p-toluenesulfonic acid and p-methoxyphenol, and finally add ethanol, heat to 100-110°C at a rate of 5°C / min, and then maintain the temperature at 300rpm and stir for 4-8h; A2: After the stirring reaction in step A1 is completed, the reaction mixture is naturally cooled to room temperature, filtered, and then allowed to stand for 8 to 12 hours. The organic layer is separated and collected, and 10 wt% sodium carbonate solution is added to the organic layer in three batches, stirred and mixed, and then washed with deionized water until neutral, dried over anhydrous sodium sulfate, evaporated on a rotary evaporator at 40 to 50° C. for 2 to 4 hours, and finally dried under vacuum at 40° C. to constant weight to obtain modified squalane.
[0018] Preferably, the ratio of squalane, linoleic acid, p-toluenesulfonic acid, p-methoxyphenol and ethanol used in step A1 is 3 g: 2-4 g: 0.05-0.1 g: 1-1.5 mg: 15-20 mL.
[0019] Preferably, the ratio of the sodium carbonate solution to p-toluenesulfonic acid in step A2 is 10 mL: 1 g.
[0020] Preferably, the preservative is any one of phenoxyethanol, caprylhydroxamic acid and sodium benzoate.
[0021] Preferably, the humectant is any one of glycerin, butylene glycol, propylene glycol, 1,3-propanediol and 1,2-hexanediol.
[0022] Preferably, the antioxidant is any one of tocopheryl acetate, tocopherol, ubiquinone, ascorbyl tetraisopalmitate and tea polyphenols.
[0023] Preferably, another aspect of the present invention is to provide a method for preparing a composition having the function of regulating exocrine glands, and the specific preparation steps are as follows: S1: Add octyl polymethicone, polydimethylsiloxane, modified squalane, lauryl PEG-9 polydimethylsiloxyethyl polydimethicone, cetyl PEG / PPG-10 / 1 polydimethicone and hydrogenated polyisobutylene into an oil phase container according to weight parts, heat to raise the temperature to 60-70° C., stir and mix evenly to obtain an oil phase; S2: adding two thirds of disteardimethylammonium hectorite by weight to deionized water, heating the mixture to 40° C. in a water bath, stirring and dispersing the mixture to form a suspension, and then adding a moisturizer and a preservative, stirring and mixing the mixture to obtain an aqueous phase; S3: heating the oil phase prepared in step S1 to 60-70°C, then gradually adding it to the water phase prepared in step S2 at the same temperature, stirring at a speed of 6000-10000 rpm for 15-30 minutes to obtain an emulsion; then continuously stirring at a speed of 200 rpm, and slowly cooling the emulsion to 40°C at a cooling rate of 0.5-1°C / min, and then sequentially adding various extracts in the composite natural extract, and fully stirring; S4: After completing the operation in step S3, maintain the temperature at 40°C, add the remaining one-third by weight of disteardimethylammonium hectorite to the obtained product solution, control the rotation speed to 100-200 rpm, stir for 10-15 minutes, then cool to room temperature, add an antioxidant, continue stirring for 5-10 minutes, filter through a 100 μm filter, and obtain a composition with the function of regulating exocrine glands.
[0024] The beneficial effects of the present invention are as follows: The purslane extract, peony extract, Rhodiola rosea root extract and loquat leaf extract used in the present invention have significant anti-inflammatory and antioxidant functions, which can reduce skin inflammation caused by exocrine gland dysfunction by inhibiting the production of pro-inflammatory factors; these extracts can also neutralize free radicals, reduce the damage of oxidative stress to skin cells, and thus maintain the skin barrier function. In addition, loquat leaf extract and Platycladus orientalis leaf extract have the ability to regulate sebum secretion, wherein loquat leaf extract inhibits sebaceous gland activity through polyphenolic compounds, effectively reduces excessive sebum secretion, and prevents oily skin problems; Platycladus orientalis leaf extract prevents acne and inflammation caused by excessive sebum through antibacterial and anti-inflammatory effects, and Cynomorium songaricum extract has the effect of enhancing the skin's moisturizing ability and can improve the skin's moisture retention ability. It prevents water loss by enhancing the skin's barrier function, ensuring that the skin will not become dry after reducing oil secretion, loquat leaf extract reduces sebum secretion, and Cynomorium songaricum extract ensures that the skin is sufficiently hydrated to achieve water-oil balance. Rhodiola rosea root extract and peony extract indirectly support the balance of sebum secretion through their antioxidant and anti-inflammatory properties, avoiding excessive oiliness or dryness of the skin. Portulaca oleracea extract and Rhodiola rosea root extract further promote the self-repair of skin cells and enhance the skin's regeneration ability, while peony extract and crocus flower extract enhance the skin's barrier function and promote the repair and regeneration of skin cells through their antioxidant and anti-inflammatory effects.
[0025] The present invention utilizes the water absorption and swelling of disteardimethylammonium hectorite and the interlamellar action to prepare an emulsion-gel mixed form, which has a light texture and is suitable for regulating oil secretion, while not increasing the burden on the skin. The form has good permeability, and can penetrate the effective ingredients of the extract into the skin, giving full play to its anti-inflammatory, antioxidant and repairing effects. In addition, the emulsion-gel form helps to maintain the water-oil balance of the skin, and is particularly suitable for the sebum regulating function of loquat leaf extract and Platycladus orientalis leaf extract, preventing the skin from being too greasy or dry, and the moisturizing and repairing effects of Selaginella extract and Crocus flower extract are enhanced in this form, while maintaining the breathability of the skin. The present invention prepares squalane linoleate by linoleic acid esterification and modification of squalane, linoleic acid is an important component naturally present in sebum, and has the function of regulating the function of sebaceous glands, and squalane linoleate can penetrate into the sebaceous glands to regulate oil secretion, and is particularly suitable for the balance regulation of oily skin. In addition, squalane itself is an important component of the skin barrier. When combined with linoleic acid, it not only supplements the essential fatty acids lacking in sebum, but also enhances the skin barrier function and prevents water loss. Loquat leaf extract inhibits sebaceous gland activity through its polyphenolic compounds, reduces excessive sebum secretion, and complements squalane linoleate to maintain the water-oil balance of the skin and prevent oily skin problems; Platycladus orientalis leaf extract reduces acne and inflammation caused by excessive sebum through antibacterial, anti-inflammatory and sebum regulating effects, and further optimizes the balance of sebum secretion; the antioxidant and anti-inflammatory effects of squalane linoleate can reduce oxidative stress damage to the skin and promote skin barrier repair. Portulaca oleracea extract enhances antioxidant protection and reduces the accumulation of free radicals in the skin. The combination of the two can reduce skin inflammation, repair damage caused by inflammation or oxidative stress, and enhance the overall health of the skin. BRIEF DESCRIPTION OF THE DRAWINGS
[0026] In order to more clearly illustrate the technical solutions in the present invention or the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings in the following description are only for the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0027] Figure 1 is the DPPH radical scavenging rate of the compositions prepared in Examples 1 to 4 of the present invention and Comparative Examples 1 to 3; Figure 2 It is a test result diagram of the water replenishment of the compositions prepared in Examples 2 to 3 of the present invention and Comparative Examples 1 to 3; Figure 3 It is a test chart of the anti-inflammatory activity of the compositions prepared in Examples 2 to 3 of the present invention and Comparative Examples 1 to 3; Figure 4It is a test chart of the sebum regulating ability of the compositions prepared in Examples 2 to 3 of the present invention and Comparative Examples 1 to 3. DETAILED DESCRIPTION
[0028] The technical solution of the present invention will be clearly and completely described below in conjunction with the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of them; based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention. It should be noted that, unless otherwise specified, the raw materials involved in the present invention are purchased through conventional commercial channels.
[0029] Embodiment 1: A composition having the function of regulating exocrine glands, the composition is composed of the following raw materials in parts by weight: 30 parts of composite natural extracts, 20 parts of octyl polymethicone, 15 parts of polydimethylsiloxane, 10 parts of modified squalane, 5 parts of lauryl PEG-9 polydimethylsiloxyethyl polydimethylsiloxane, 3 parts of cetyl PEG / PPG-10 / 1 polydimethylsiloxane, 5 parts of hydrogenated polyisobutene, 7 parts of disteardimonium hectorite, 0.5 parts of preservatives, 5 parts of moisturizers and 0.5 parts of antioxidants, and 100 parts of deionized water; The composite natural extract is composed of the following raw materials in parts by weight: 5 parts of purslane extract, 3 parts of Rhodiola rosea root extract, 2 parts of peony extract, 2 parts of chamomile oil, 3 parts of Platycladus orientalis leaf extract, 4 parts of loquat leaf extract, 2 parts of saffron flower extract, 3 parts of Cynomorium songaricum extract and 3 parts of Selaginella extract.
[0030] (1): The purslane extract is prepared by a hot reflux extraction process using ethanol as a solvent; (2): The Rhodiola rosea root extract is prepared by a hot reflux extraction process using ethanol as a solvent; (3): The peony extract is prepared by a hot reflux extraction process using ethanol as a solvent; (4): The chamomile oil is prepared by a steam distillation extraction process using water as a solvent; (5): The Platycladus orientalis leaf extract is prepared by a hot reflux extraction process using ethanol as a solvent; (6): The loquat leaf extract is prepared by a hot reflux extraction process using ethanol as a solvent; (7): The crocus flower extract is prepared by using an ethanol-water mixed solvent and an ethanol-water reflux extraction process; (8): The Cynomorium songaricum extract is prepared by ultrasonic-assisted extraction using an ethanol-water mixed solvent; (9): The Selaginella extract is prepared by ultrasonic-assisted extraction using an ethanol-water mixed solvent; (10): Preparation of modified squalane: A1: Add 30g squalane and 20g linoleic acid into a reactor, then add 0.5g p-toluenesulfonic acid and 10mg p-methoxyphenol, and finally add 150mL ethanol, heat to 100℃ at a rate of 5℃ / min, and then maintain the temperature at 300rpm and stir for 8h; A2: After the stirring reaction in step A1 is completed, the reaction mixture is naturally cooled to room temperature, filtered, and then allowed to stand for 8 hours, the organic layer is separated and collected, 5 mL of a 10 wt% sodium carbonate solution is added to the organic layer in three batches, stirred and mixed, and then washed with deionized water until neutral, dried over anhydrous sodium sulfate, evaporated at 40° C. for 4 hours using a rotary evaporator, and finally dried in vacuo at 40° C. to constant weight to obtain modified squalane; (11): Preparation of a composition for regulating exocrine gland function: S1: Add octyl polymethicone, polydimethylsiloxane, modified squalane, lauryl PEG-9 polydimethylsiloxyethyl polydimethicone, cetyl PEG / PPG-10 / 1 polydimethicone and hydrogenated polyisobutylene into an oil phase container according to weight portions, heat to raise the temperature to 60° C., stir and mix evenly to obtain an oil phase; S2: adding two thirds of disteardimethylammonium hectorite by weight to deionized water, heating the mixture to 40° C. in a water bath, stirring and dispersing the mixture to form a suspension, and then adding butylene glycol and phenoxyethanol, stirring and mixing the mixture to obtain an aqueous phase; S3: heating the oil phase prepared in step S1 to 60°C, then gradually adding it to the water phase prepared in step S2 at the same temperature, stirring at a speed of 6000 rpm for 30 minutes to obtain an emulsion; then continuously stirring at a speed of 200 rpm, and slowly cooling the emulsion to 40°C at a cooling rate of 0.5°C / min, and then sequentially adding various extracts in the composite natural extract, and fully stirring; S4: After completing the operation in step S3, maintain the temperature at 40°C, add the remaining one-third by weight of disteardimethylammonium hectorite to the resulting product solution, control the rotation speed to 100 rpm, stir for 15 minutes, then cool to room temperature, add tocopherol acetate, continue stirring for 5 minutes, filter through a 100 μm filter to obtain a composition with the function of regulating exocrine glands.
[0031] Embodiment 2: A composition having the function of regulating exocrine glands, the composition is composed of the following raw materials in parts by weight: 38 parts of composite natural extracts, 25 parts of octyl polymethicone, 20 parts of polydimethicone, 15 parts of modified squalane, 7 parts of lauryl PEG-9 polydimethylsiloxyethyl polydimethicone, 5 parts of cetyl PEG / PPG-10 / 1 polydimethicone, 7 parts of hydrogenated polyisobutene, 10 parts of disteardimonium hectorite, 0.6 parts of preservatives, 7 parts of moisturizers and 0.7 parts of antioxidants, and 120 parts of deionized water; The composite natural extract is composed of the following raw materials in parts by weight: 8 parts of purslane extract, 4 parts of Rhodiola rosea root extract, 3 parts of peony extract, 3 parts of chamomile oil, 6 parts of Platycladus orientalis leaf extract, 8 parts of loquat leaf extract, 4 parts of saffron flower extract, 5 parts of Cynomorium songaricum extract and 6 parts of Selaginella extract.
[0032] (1): The purslane extract is prepared by a hot reflux extraction process using ethanol as a solvent; (2): The Rhodiola rosea root extract is prepared by a hot reflux extraction process using ethanol as a solvent; (3): The peony extract is prepared by a hot reflux extraction process using ethanol as a solvent; (4): The chamomile oil is prepared by a steam distillation extraction process using water as a solvent; (5): The Platycladus orientalis leaf extract is prepared by a hot reflux extraction process using ethanol as a solvent; (6): The loquat leaf extract is prepared by a hot reflux extraction process using ethanol as a solvent; (7): The crocus flower extract is prepared by using an ethanol-water mixed solvent and an ethanol-water reflux extraction process; (8): The Cynomorium songaricum extract is prepared by ultrasonic-assisted extraction using an ethanol-water mixed solvent; (9): The Selaginella extract is prepared by ultrasonic-assisted extraction using an ethanol-water mixed solvent; (10): Preparation of modified squalane: A1: Add 30g squalane and 35g linoleic acid into a reactor, then add 0.9g p-toluenesulfonic acid and 14mg p-methoxyphenol, and finally add 180mL ethanol, heat to 110°C at a rate of 5°C / min, and then maintain the temperature at 300rpm and stir for 6h; A2: After the stirring reaction in step A1 is completed, the reaction mixture is naturally cooled to room temperature, filtered, and then allowed to stand for 10 hours. The organic layer is separated and collected, and 9 mL of a 10 wt% sodium carbonate solution is added to the organic layer in three batches, stirred and mixed, and then washed with deionized water until neutral, dried over anhydrous sodium sulfate, and evaporated at 45° C. for 4 hours using a rotary evaporator, and finally dried at 40° C. in a vacuum oven to constant weight to obtain modified squalane; (11): Preparation of a composition for regulating exocrine gland function: S1: Add octyl polymethicone, polydimethylsiloxane, modified squalane, lauryl PEG-9 polydimethylsiloxyethyl polydimethicone, cetyl PEG / PPG-10 / 1 polydimethicone and hydrogenated polyisobutylene into an oil phase container according to weight portions, heat to raise the temperature to 65° C., stir and mix evenly to obtain an oil phase; S2: adding two thirds of disteardimethylammonium hectorite by weight to deionized water, heating the mixture to 40° C. in a water bath, stirring and dispersing the mixture to form a suspension, and then adding propylene glycol and sodium benzoate, stirring and mixing the mixture to obtain an aqueous phase; S3: heating the oil phase prepared in step S1 to 65°C, then gradually adding it to the water phase prepared in step S2 at the same temperature, stirring at a speed of 10000 rpm for 20 minutes to obtain an emulsion; then continuously stirring at a speed of 200 rpm, and slowly cooling the emulsion to 40°C at a cooling rate of 1°C / min, and then sequentially adding various extracts in the composite natural extract, and fully stirring; S4: After completing the operation in step S3, maintain the temperature at 40°C, add the remaining one-third by weight of disteardimethylammonium hectorite to the obtained product solution, control the rotation speed to 150 rpm, stir for 15 minutes, then cool to room temperature, add tocopherol, continue stirring for 8 minutes, filter through a 100 μm filter, and obtain a composition with the function of regulating exocrine glands.
[0033] Embodiment 3: A composition having the function of regulating exocrine glands, the composition is composed of the following raw materials in parts by weight: 35 parts of composite natural extracts, 28 parts of octyl polymethicone, 22 parts of polydimethicone, 18 parts of modified squalane, 8 parts of lauryl PEG-9 polydimethylsiloxyethyl polydimethicone, 5 parts of cetyl PEG / PPG-10 / 1 polydimethicone, 6 parts of hydrogenated polyisobutene, 12 parts of disteardimonium hectorite, 0.8 parts of preservatives, 8 parts of moisturizers and 0.8 parts of antioxidants, and 110 parts of deionized water; The composite natural extract is composed of the following raw materials in parts by weight: 8 parts of purslane extract, 3 parts of Rhodiola rosea root extract, 3 parts of peony extract, 3 parts of chamomile oil, 4 parts of Platycladus orientalis leaf extract, 5 parts of loquat leaf extract, 3 parts of saffron flower extract, 3 parts of Cynomorium songaricum extract and 4 parts of Selaginella extract.
[0034] (1): The purslane extract is prepared by a hot reflux extraction process using ethanol as a solvent; (2): The Rhodiola rosea root extract is prepared by a hot reflux extraction process using ethanol as a solvent; (3): The peony extract is prepared by a hot reflux extraction process using ethanol as a solvent; (4): The chamomile oil is prepared by a steam distillation extraction process using water as a solvent; (5): The Platycladus orientalis leaf extract is prepared by a hot reflux extraction process using ethanol as a solvent; (6): The loquat leaf extract is prepared by a hot reflux extraction process using ethanol as a solvent; (7): The crocus flower extract is prepared by using an ethanol-water mixed solvent and an ethanol-water reflux extraction process; (8): The Cynomorium songaricum extract is prepared by ultrasonic-assisted extraction using an ethanol-water mixed solvent; (9): The Selaginella extract is prepared by ultrasonic-assisted extraction using an ethanol-water mixed solvent; (10): Preparation of modified squalane: A1: Add 30g squalane and 30g linoleic acid into a reactor, then add 0.8g p-toluenesulfonic acid and 12mg p-methoxyphenol, and finally add 170mL ethanol, heat to 105°C at a rate of 5°C / min, and then maintain the temperature at 300rpm and stir for 5h; A2: After the stirring reaction in step A1 is completed, the reaction mixture is naturally cooled to room temperature, filtered, and then allowed to stand for 12 hours, the organic layer is separated and collected, 8 mL of a 10 wt% sodium carbonate solution is added to the organic layer in three batches, stirred and mixed, and then washed with deionized water until neutral, dried over anhydrous sodium sulfate, evaporated on a rotary evaporator at 45° C. for 3 hours, and finally dried in vacuo at 40° C. to constant weight to obtain modified squalane; (11): Preparation of a composition for regulating exocrine gland function: S1: Add octyl polymethicone, polydimethylsiloxane, modified squalane, lauryl PEG-9 polydimethylsiloxyethyl polydimethicone, cetyl PEG / PPG-10 / 1 polydimethicone and hydrogenated polyisobutylene into an oil phase container according to weight portions, heat to raise the temperature to 68° C., stir and mix evenly to obtain an oil phase; S2: adding two thirds of disteardimethylammonium hectorite by weight to deionized water, heating the mixture to 40° C. in a water bath, stirring and dispersing the mixture to form a suspension, and then adding glycerin and phenoxyethanol, stirring and mixing the mixture to obtain an aqueous phase; S3: heating the oil phase prepared in step S1 to 70°C, and then gradually adding it to the water phase prepared in step S2 at the same temperature, stirring at a speed of 8000 rpm for 25 minutes to obtain an emulsion; then continuously stirring at a speed of 200 rpm, and slowly cooling the emulsion to 40°C at a cooling rate of 0.8°C / min, and then sequentially adding various extracts in the composite natural extract, and fully stirring; S4: After completing the operation in step S3, maintain the temperature at 40°C, add the remaining one-third by weight of disteardimethylammonium hectorite to the obtained product solution, control the rotation speed to 150 rpm, stir for 12 minutes, then cool to room temperature, add ubiquinone, continue stirring for 8 minutes, filter with a 100 μm filter, and obtain a composition with the function of regulating exocrine glands.
[0035] Embodiment 4: A composition having the function of regulating exocrine glands, the composition is composed of the following raw materials in parts by weight: 40 parts of composite natural extracts, 30 parts of octyl polymethicone, 25 parts of polydimethicone, 20 parts of modified squalane, 10 parts of lauryl PEG-9 polydimethylsiloxyethyl polydimethicone, 7 parts of cetyl PEG / PPG-10 / 1 polydimethicone, 10 parts of hydrogenated polyisobutene, 14 parts of disteardimonium hectorite, 1 part of preservative, 10 parts of moisturizer and 1 part of antioxidant, 120 parts of deionized water; The composite natural extract is composed of the following raw materials in parts by weight: 10 parts of purslane extract, 5 parts of Rhodiola rosea root extract, 5 parts of peony extract, 4 parts of chamomile oil, 6 parts of Platycladus orientalis leaf extract, 8 parts of loquat leaf extract, 5 parts of saffron flower extract, 5 parts of Cynomorium songaricum extract and 6 parts of Selaginella extract.
[0036] (1): The purslane extract is prepared by a hot reflux extraction process using ethanol as a solvent; (2): The Rhodiola rosea root extract is prepared by a hot reflux extraction process using ethanol as a solvent; (3): The peony extract is prepared by a hot reflux extraction process using ethanol as a solvent; (4): The chamomile oil is prepared by a steam distillation extraction process using water as a solvent; (5): The Platycladus orientalis leaf extract is prepared by a hot reflux extraction process using ethanol as a solvent; (6): The loquat leaf extract is prepared by a hot reflux extraction process using ethanol as a solvent; (7): The crocus flower extract is prepared by using an ethanol-water mixed solvent and an ethanol-water reflux extraction process; (8): The Cynomorium songaricum extract is prepared by ultrasonic-assisted extraction using an ethanol-water mixed solvent; (9): The Selaginella extract is prepared by ultrasonic-assisted extraction using an ethanol-water mixed solvent; (10): Preparation of modified squalane: A1: Add 30g squalane and 40g linoleic acid into a reactor, then add 1g p-toluenesulfonic acid and 15mg p-methoxyphenol, and finally add 200mL ethanol, heat to 110°C at a rate of 5°C / min, and then maintain the temperature at 300rpm and stir for 4h; A2: After the stirring reaction in step A1 is completed, the reaction mixture is naturally cooled to room temperature, filtered, and then allowed to stand for 12 hours, the organic layer is separated and collected, 10 mL of a 10 wt% sodium carbonate solution is added to the organic layer in three batches, stirred and mixed, and then washed with deionized water until neutral, dried over anhydrous sodium sulfate, evaporated at 50° C. for 2 hours using a rotary evaporator, and finally dried in vacuo at 40° C. to constant weight to obtain modified squalane; (11): Preparation of a composition for regulating exocrine gland function: S1: Add octyl polymethicone, polydimethylsiloxane, modified squalane, lauryl PEG-9 polydimethylsiloxyethyl polydimethicone, cetyl PEG / PPG-10 / 1 polydimethicone and hydrogenated polyisobutylene into an oil phase container according to weight portions, heat to raise the temperature to 70° C., stir and mix evenly to obtain an oil phase; S2: adding two thirds of disteardimethylammonium hectorite by weight to deionized water, heating the mixture to 40° C. in a water bath, stirring and dispersing the mixture to form a suspension, and then adding 1,3-propylene glycol and caprylhydroxamic acid, stirring and mixing the mixture to obtain an aqueous phase; S3: heating the oil phase prepared in step S1 to 70°C, and then gradually adding it to the water phase prepared in step S2 at the same temperature, stirring at a speed of 10000 rpm for 15 minutes to obtain an emulsion; then continuously stirring at a speed of 200 rpm, and slowly cooling the emulsion to 40°C at a cooling rate of 1°C / min, and then sequentially adding various extracts in the composite natural extract, and fully stirring; S4: After completing the operation in step S3, maintain the temperature at 40°C, add the remaining one-third by weight of disteardimethylammonium hectorite to the resulting product solution, control the rotation speed to 200 rpm, stir for 10 minutes, then cool to room temperature, add ascorbic acid tetraisopalmitate, continue stirring for 10 minutes, filter through a 100 μm filter to obtain a composition with the function of regulating exocrine glands.
[0037] Comparative Example 1: The operation of Comparative Example 1 is basically the same as that of Example 2, except that loquat leaf extract and Platycladus orientalis leaf extract are not added in Comparative Example 1.
[0038] Comparative Example 2: The operation of Comparative Example 2 is substantially the same as that of Example 2, except that squalane is used in place of modified squalane in Comparative Example 2.
[0039] Comparative Example 3: The operation of Comparative Example 3 is basically the same as that of Example 3, except that no Portulaca oleracea extract and Rhodiola rosea root extract are added in Comparative Example 3.
[0040] Performance Testing: DPPH free radical scavenging rate test: Take 2mL DPPH solution and 2mL sample solution to be tested (0.1mL of the composition prepared in Examples 1 to 4 and the composition prepared in Comparative Examples 1 to 3 are respectively dissolved in 5mL anhydrous ethanol), mix well, place in dark for 30 minutes, and measure the absorbance at 517nm with anhydrous ethanol solution as reference. The DPPH solution is a solution with a concentration of 0.1mM prepared with anhydrous ethanol as solvent. Calculate the DPPH free radical scavenging rate (scavenging rate = [1-(absorbance of the mixture of sample and DPPH-absorbance of the sample solution without DPPH / absorbance of the solution containing only DPPH] × 100%), repeat the test 3 times, take the average value, and the results are as follows: Figure 1 shown.
[0041] Depend on Figure 1 The results show that the composition prepared by the present invention has an excellent DPPH free radical scavenging rate and excellent antioxidant properties; from the results of Comparative Example 1 and Example 2, it can be seen that the main functions of loquat leaf extract and Platycladus orientalis leaf extract are to regulate sebum secretion and antibacterial and anti-inflammatory, and their contribution to antioxidant properties is relatively small; from the results of Comparative Example 2 and Example 2, it can be seen that the modified squalane not only retains the basic properties of squalane, but also increases the antioxidant properties, especially in repairing the skin barrier and reducing oxidative stress, replacing the modified squalane with squalane significantly reduces the antioxidant effect; Portulaca oleracea extract and Rhodiola rosea root extract have significant anti-inflammatory and antioxidant effects, and the absence of these two components has a significant effect on the overall antioxidant capacity.
[0042] Moisturizing test: 20 healthy volunteers aged between 25 and 45 were selected to ensure that their skin types were suitable for the test (normal to dry skin). It was ensured that no other skin care products were used at least 24 hours before the test. Before the test, a mild non-irritating cleanser was used to clean the facial test area (forehead), and then rinsed with deionized water. After cleaning, wait for 30 minutes to allow the skin to return to its natural state. A skin moisture meter (Corneometer) was used to measure the skin moisture content of the test area on the face of the subject before using the product. Each area was measured 3 times, and the average value was recorded as the baseline data. The tested composition (the composition prepared in Examples 2 to 3 and the composition prepared in Comparative Examples 1 to 3) was evenly applied to the test area on the face of the subject, and the application amount was 2 mg / cm 2 , measured at 1h, 2h, 4h, and 8h after application, using a skin moisture meter to measure the moisture content of the subjects' skin, measuring each area 3 times, recording the average value, and calculating the moisturizing improvement rate (%) = (skin moisture content at time point - baseline skin moisture content) / baseline skin moisture content × 100%. The results are as follows Figure 2 shown.
[0043] Depend on Figure 2 As can be seen from the results, the composition prepared by the present invention can effectively achieve moisturizing performance. From the results of Comparative Example 1 and Example 2, it can be seen that the main role of loquat leaf extract and Platycladus orientalis leaf extract in the formula is to regulate sebum secretion and provide anti-inflammatory effects, and their contribution to direct moisturizing is relatively small; from the results of Comparative Example 2 and Example 2, it can be seen that modified squalane not only moisturizes, but also enhances the skin barrier function and reduces water loss. Substitution with squalane significantly reduces this enhanced moisturizing and barrier repair effect; from the results of Comparative Example 3 and Example 3, it can be seen that Portulaca oleracea extract and Rhodiola rosea root extract have significant anti-inflammatory and repair effects, and can indirectly enhance the moisturizing performance of the skin. The lack of these two ingredients will have a negative impact on the overall moisturizing effect.
[0044] Anti-inflammatory test: Mouse macrophages were inoculated in sterile culture medium (DMEM + 10% fetal bovine serum) at 37°C and 5% CO2 concentration. After 24 h of culture, the cells were diluted to 1×10 5 / mL cell solution, each group of cell solution is set to 1mL; take the compositions prepared in Examples 2 to 3 and Comparative Examples 1 to 3 and physiological saline as the control group, take 0.1mL of each sample, add these samples to the above cell solution in turn, after mixing, take 100μL of sample from each group and add it to the ELISA plate pre-coated with TNF-α antibody, let it stand at room temperature for 2h, wash it three times with PBS buffer, add 100μL of secondary antibody labeled with horseradish peroxidase (HRP) diluted 1000 times, let it stand at room temperature for 1h, wash it three times with PBS buffer, add 100μL of 0.1mg / mL TMB solution, let it stand for 15min, add 100μL of 1moL / L hydrochloric acid, read the absorbance at 450nm using an enzyme reader, calculate the anti-inflammatory activity [anti-inflammatory activity (%) = (average TNF-α concentration of the control group - average TNF-α concentration of the embodiment) / average TNF-α concentration of the control group × 100%], all samples were tested three times, and the results were averaged. The results are as follows Figure 3 shown.
[0045] Depend on Figure 3 As a result, it can be seen that the composition prepared by the present invention has an excellent anti-inflammatory effect and can effectively inhibit the occurrence of inflammation. From the results of Comparative Example 1 and Example 2, it can be seen that the anti-inflammatory performance is significantly affected by the lack of synergistic effect of loquat leaf extract and Platycladus orientalis leaf extract with other anti-inflammatory ingredients in regulating sebum and inhibiting inflammatory factors; from the results of Comparative Example 2 and Example 2, it can be seen that although squalane has a certain skin repair function, it lacks the anti-inflammatory and sebum regulating functions of linoleic acid. After squalane is used to replace the modified squalane, there is a lack of anti-inflammatory enhancement effect, and the synergy is significantly reduced; from the results of Comparative Example 3 and Example 3, it can be seen that the anti-inflammatory property of Portulaca oleracea extract and Rhodiola rosea root extract is significantly reduced by the lack of significant synergy with other ingredients in anti-inflammatory and skin repair.
[0046] Sebum regulation ability test: 20 healthy volunteers aged between 25 and 45 were selected to ensure that their skin types were suitable for the test (normal to dry skin). It was ensured that no other skin care products were used at least 24 hours before the test. Before the test, a mild non-irritating cleanser was used to clean the facial test area (forehead), and then rinsed with deionized water. The skin was placed in an environment with a temperature of 22°C and a relative humidity of 60% for 60 minutes to allow the skin to return to its natural state. A sebum meter (Sebumeter) was used to measure the sebum level in the cleaned facial test area. Each area was measured 3 times, and the average value was recorded as the baseline data. The tested composition (the composition prepared in Examples 2 to 3 and the composition prepared in Comparative Examples 1 to 3) was evenly applied to the facial test area, and the application amount was 2 mg / cm 2Wait for 30 minutes, measure the sebum level 1h, 3h and 6h after application, record the average of the three measurements, and calculate the sebum change rate (%) = (sebum level at time point - baseline sebum level) / baseline sebum level × 100%. The results are as follows Figure 4 shown.
[0047] Depend on Figure 4 The results show that the composition prepared by the present invention has excellent sebum regulating ability. From the results of Comparative Example 1 and Example 2, it can be seen that due to the lack of loquat leaf extract and Platycladus orientalis leaf extract, the synergistic effect of sebum regulation is significantly reduced, and sebum secretion is significantly increased; from the results of Comparative Example 2 and Example 2, it can be seen that the use of squalane to replace modified squalane loses the sebum regulating function of linoleic acid, weakens the synergistic effect with other anti-inflammatory and antioxidant extracts, and sebum secretion is significantly increased; from the results of Comparative Example 3 and Example 3, it can be seen that the lack of Portulaca oleracea extract and Rhodiola rosea root extract leads to a weakening of the indirect supporting effect of sebum regulation.
[0048] Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that various changes, modifications, substitutions and variations may be made to the embodiments without departing from the principles and spirit of the present invention, and that the scope of the present invention is defined by the appended claims and their equivalents.
Claims
1. A composition for regulating exocrine gland function, characterized in that: The composition is composed of the following raw materials in parts by weight: 30 to 40 parts of composite natural extracts, 20 to 30 parts of octyl polymethylsiloxane, 15 to 25 parts of polydimethylsiloxane, 10 to 20 parts of modified squalane, 5 to 10 parts of lauryl PEG-9 polydimethylsiloxyethyl polydimethylsiloxane, 3 to 7 parts of cetyl PEG / PPG-10 / 1 polydimethylsiloxane, 5 to 10 parts of hydrogenated polyisobutylene, 7 to 14 parts of disteardimonium hectorite, 0.5 to 1 part of preservatives, 5 to 10 parts of moisturizers and 0.5 to 1 part of antioxidants, and 100 to 120 parts of deionized water.
2. A composition for regulating exocrine gland function according to claim 1, characterized in that: The composite natural extract is composed of the following raw materials in parts by weight: 5 to 10 parts of purslane extract, 3 to 5 parts of Rhodiola rosea root extract, 2 to 5 parts of peony extract, 2 to 4 parts of chamomile oil, 3 to 6 parts of Platycladus orientalis leaf extract, 4 to 8 parts of loquat leaf extract, 2 to 5 parts of saffron flower extract, 3 to 5 parts of Cynomorium songaricum extract and 3 to 6 parts of Selaginella extract.
3. A composition for regulating exocrine gland function according to claim 2, characterized in that: The specific preparation steps of the modified squalane are as follows: A1: Add squalane and linoleic acid into a reactor, then add p-toluenesulfonic acid and p-methoxyphenol, and finally add ethanol, raise the temperature to 100-110°C at a rate of 5°C / min, and then maintain the temperature and stir to react; A2: After the stirring reaction in step A1 is completed, the reaction mixture is naturally cooled to room temperature, filtered, and then allowed to stand, the organic layer is separated and collected, and sodium carbonate solution is added to the organic layer in three batches, stirred and mixed, and then washed with deionized water until neutral, dried with anhydrous sodium sulfate, evaporated and concentrated with a rotary evaporator, and finally vacuum dried to constant weight to obtain modified squalane.
4. A composition for regulating exocrine gland function according to claim 3, characterized in that: The ratio of squalane, linoleic acid, p-toluenesulfonic acid, p-methoxyphenol and ethanol used in step A1 is 3g:2-4g:0.05-0.1g:1-1.5mg:15-20mL; the ratio of sodium carbonate solution to p-toluenesulfonic acid used in step A2 is 10mL:1g.
5. A composition for regulating exocrine gland function according to claim 4, characterized in that: The preservative is any one of phenoxyethanol, caprylhydroxamic acid and sodium benzoate.
6. The composition for regulating exocrine gland function according to claim 5, characterized in that: The moisturizing agent is any one of glycerin, butylene glycol, propylene glycol, 1,3-propanediol and 1,2-hexanediol.
7. The composition for regulating exocrine gland function according to claim 6, characterized in that: The antioxidant is any one of tocopheryl acetate, tocopherol, ubiquinone, ascorbyl tetraisopalmitate and tea polyphenols.
8. A composition for regulating exocrine gland function according to any one of claims 1 to 7, characterized in that: The specific preparation steps are as follows: S1: Add octyl polymethicone, polydimethylsiloxane, modified squalane, lauryl PEG-9 polydimethylsiloxyethyl polydimethicone, cetyl PEG / PPG-10 / 1 polydimethicone and hydrogenated polyisobutylene into an oil phase container according to weight parts, heat to raise the temperature to 60-70° C., stir and mix evenly to obtain an oil phase; S2: adding two thirds of disteardimethylammonium hectorite by weight to deionized water, heating in a water bath to control the temperature, stirring and dispersing to form a suspension, then adding a moisturizer and a preservative, stirring and mixing to obtain an aqueous phase; S3: heating the oil phase prepared in step S1 to 60-70°C, then gradually adding it to the water phase prepared in step S2 at the same temperature, stirring at a speed of 6000-10000 rpm for 15-30 minutes to obtain an emulsion; then continuously stirring at a speed of 200 rpm, and slowly cooling the emulsion to 40°C at a cooling rate of 0.5-1°C / min, and then sequentially adding various extracts in the composite natural extract, and fully stirring; S4: After completing the operation in step S3, maintain the temperature at 40°C, add the remaining one-third by weight of disteardimethylammonium hectorite to the obtained product solution, control the rotation speed to 100-200 rpm, stir for 10-15 minutes, then cool to room temperature, add an antioxidant, continue stirring for 5-10 minutes, filter through a sieve, and obtain a composition having the function of regulating exocrine glands.
